{"id":"https://openalex.org/W2891434839","doi":"https://doi.org/10.1200/jco.2018.36.34_suppl.154","title":"Quality of life and psychological distress in patients with acute myeloid leukemia (AML).","display_name":"Quality of life and psychological distress in patients with acute myeloid leukemia (AML).","publication_year":2018,"publication_date":"2018-11-28","ids":{"openalex":"https://openalex.org/W2891434839","doi":"https://doi.org/10.1200/jco.2018.36.34_suppl.154","mag":"2891434839"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.34_suppl.154","doi":"https://doi.org/10.1200/jco.2018.36.34_suppl.154","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.34_suppl.154","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039433783","display_name":"Netana H. Markovitz","orcid":"https://orcid.org/0000-0002-7058-9653","observed_orcids":["https://orcid.org/0000-0002-7058-9653"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Netana Markovitz","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022593739","display_name":"Lauren P. Waldman","orcid":"https://orcid.org/0000-0003-4883-6010","observed_orcids":["https://orcid.org/0000-0003-4883-6010"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren Waldman","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027842612","display_name":"Julia Carp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia Carp","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064859618","display_name":"Lara N. Traeger","orcid":"https://orcid.org/0000-0002-8175-5725","observed_orcids":["https://orcid.org/0000-0002-8175-5725"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lara Traeger","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091710463","display_name":"Gregory Alan Abel","orcid":"https://orcid.org/0000-0003-1100-2813","observed_orcids":["https://orcid.org/0000-0003-1100-2813"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory A. Abel","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017066639","display_name":"Joseph A. Greer","orcid":"https://orcid.org/0000-0002-8503-8360","observed_orcids":["https://orcid.org/0000-0002-8503-8360","https://orcid.org/0000-0002-0979-4076"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Greer","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010057352","display_name":"Amir Tahmasb Fathi","orcid":"https://orcid.org/0000-0003-4907-6447","observed_orcids":["https://orcid.org/0000-0003-4907-6447"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amir Tahmasb Fathi","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090527595","display_name":"David P. Steensma","orcid":"https://orcid.org/0000-0001-5130-9284","observed_orcids":["https://orcid.org/0000-0001-5130-9284"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Steensma","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085560257","display_name":"Thomas William LeBlanc","orcid":"https://orcid.org/0000-0002-0546-7895","observed_orcids":["https://orcid.org/0000-0002-0546-7895"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas William LeBlanc","raw_affiliation_strings":["Duke University Medical Center, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC;","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. DeAngelo","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047939331","display_name":"Martha Wadleigh","orcid":"https://orcid.org/0000-0002-8191-1708","observed_orcids":["https://orcid.org/0000-0002-8191-1708"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha Wadleigh","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065595440","display_name":"Gabriela Soriano Hobbs","orcid":"https://orcid.org/0000-0002-0199-9333","observed_orcids":["https://orcid.org/0000-0002-0199-9333"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriela Hobbs","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009387581","display_name":"Andrew Mark Brunner","orcid":"https://orcid.org/0000-0002-2169-4115","observed_orcids":["https://orcid.org/0000-0002-2169-4115"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Mark Brunner","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009091754","display_name":"Philip C. Amrein","orcid":"https://orcid.org/0000-0001-7770-2623","observed_orcids":["https://orcid.org/0000-0001-7770-2623"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip C. Amrein","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Stone","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009871897","display_name":"Jennifer S. Temel","orcid":"https://orcid.org/0000-0002-7268-5921","observed_orcids":["https://orcid.org/0000-0002-7268-5921"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer S. Temel","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078852708","display_name":"Areej R El-Jawahri","orcid":"https://orcid.org/0000-0002-3556-1495","observed_orcids":["https://orcid.org/0000-0002-3556-1495"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Areej El-Jawahri","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"34_suppl","first_page":"154","last_page":"154"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11141","display_name":"Childhood Cancer Survivors' Quality of Life","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7929999828338623},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9890000224113464},{"id":"https://openalex.org/keywords/psychological-distress","display_name":"psychological distress","score":1.0},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8309999704360962},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":1.0},{"id":"https://openalex.org/keywords/intensive-chemotherapy","display_name":"intensive chemotherapy","score":0.9810000061988831},{"id":"https://openalex.org/keywords/7-3-chemotherapy","display_name":"7+3 induction chemotherapy","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.8199999928474426},{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.9020000100135803},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.968999981880188},{"id":"https://openalex.org/keywords/supportive-care","display_name":"supportive care","score":0.796999990940094},{"id":"https://openalex.org/keywords/treatment-decision-making","display_name":"treatment decision-making","score":0.7670000195503235},{"id":"https://openalex.org/keywords/hospital-anxiety-and-depression-scale","display_name":"Hospital Anxiety and Depression Scale","score":0.8939999938011169},{"id":"https://openalex.org/keywords/longitudinal-outcomes","display_name":"longitudinal outcomes","score":0.5109999775886536},{"id":"https://openalex.org/keywords/treatment-burden","display_name":"treatment burden","score":0.3050000071525574},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.42800000309944153},{"id":"https://openalex.org/keywords/geriatric-oncology","display_name":"geriatric oncology","score":0.4779999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9110997915267944},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6472671031951904},{"id":"https://openalex.org/C2778739829","wikidata":"https://www.wikidata.org/wiki/Q17027611","display_name":"Hospital Anxiety and Depression Scale","level":3,"score":0.6206873655319214},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5828149914741516},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5720115303993225},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5587624907493591},{"id":"https://openalex.org/C2987404301","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care","level":2,"score":0.5209925770759583},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.516644299030304},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.4556352198123932},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.44867751002311707},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4228953719139099},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41790539026260376},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.41028040647506714},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2570887506008148},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.21461987495422363},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.34_suppl.154","doi":"https://doi.org/10.1200/jco.2018.36.34_suppl.154","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.34_suppl.154","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2923466167","https://openalex.org/W2340335756","https://openalex.org/W3031870001","https://openalex.org/W2264492492","https://openalex.org/W4405049576","https://openalex.org/W3095569147","https://openalex.org/W636666193","https://openalex.org/W2006691924","https://openalex.org/W3111331713","https://openalex.org/W4281626706"],"abstract_inverted_index":{"154":[0],"Background:":[1],"Older":[2,277],"patients":[3,61,121,159,216,278,307],"with":[4,16,67,205,225,279,308],"AML":[5,68,280],"face":[6],"difficult":[7],"treatment":[8,314],"decisions":[9],"as":[10,33],"they":[11],"can":[12],"be":[13],"treated":[14],"either":[15],"multi-drug":[17],"\u2018intensive\u2019":[18],"chemotherapy":[19,32,80,285],"requiring":[20],"a":[21,56],"prolonged":[22],"hospitalization,":[23],"or":[24,75,129,169,178,260],"\u2018non-intensive\u2019":[25],"chemotherapy.":[26,174],"Although":[27],"clinicians":[28],"often":[29],"perceive":[30],"intensive":[31,70,165,282],"more":[34],"burdensome,":[35],"studies":[36],"comparing":[37],"older":[38,60,306],"patients\u2019":[39],"quality":[40],"of":[41,59,92,120,157,163,194,215,292,311],"life":[42],"(QOL)":[43],"and":[44,95,100,106,111,137,146,191,202,283,289],"psychological":[45,96,147,293],"distress":[46,97,148],"while":[47],"receiving":[48,69,281],"these":[49],"treatments":[50],"are":[51],"lacking.":[52],"Methods:":[53],"We":[54,86,116,153],"conducted":[55],"longitudinal":[57],"study":[58],"(\u2265":[62],"60":[63],"years)":[64],"newly":[65],"diagnosed":[66],"(i.e.":[71],"7+3:":[72],"cytarabine/anthracycline":[73],"combination)":[74],"non-intensive":[76,170,284],"(i.e.,":[77],"hypomethylating":[78],"agents)":[79],"at":[81,104],"two":[82],"tertiary":[83],"care":[84,303],"hospitals.":[85],"assessed":[87],"patient\u2019s":[88],"QOL":[89,145,240,288],"[Functional":[90],"Assessment":[91],"Cancer":[93],"Therapy-Leukemia],":[94],"[Hospital":[98],"Anxiety":[99],"Depression":[101],"Scale":[102],"[HADS]]":[103],"baseline":[105],"2,":[107],"4,":[108],"8,":[109],"12,":[110],"24":[112],"weeks":[113],"after":[114],"diagnosis.":[115],"compared":[117],"the":[118,185,195,218,298],"proportion":[119],"in":[122,217,239],"each":[123],"group":[124],"reporting":[125],"clinically":[126,199,222],"significant":[127,200,223],"depression":[128,201,250],"anxiety":[130,179,261],"(HADS":[131],"subscale":[132],"cut":[133],"off":[134],"\u2265":[135],"7)":[136],"used":[138],"mixed":[139,231],"linear":[140,232],"effects":[141,233],"models":[142],"to":[143,300],"compare":[144],"longitudinally":[149],"between":[150,184,208,228],"groups.":[151,186,209,229],"Results:":[152],"enrolled":[154],"75.2%":[155],"(100/133)":[156],"eligible":[158],"within":[160],"72":[161],"hours":[162],"initiating":[164],"(n":[166,171],"=":[167,172,242,245,248,252,255,258,263,266,269],"50)":[168,173],"Baseline":[175],"QOL,":[176],"depression,":[177,224],"symptoms":[180,271],"did":[181],"not":[182],"differ":[183],"At":[187,210],"baseline,":[188],"33.33%":[189],"(33/100)":[190],"30%":[192],"(30/100)":[193],"overall":[196,219],"cohort":[197,220],"reported":[198,221],"anxiety,":[203],"respectively,":[204],"no":[206,226,237],"differences":[207,227,238],"4":[211],"weeks,":[212],"41.98%":[213],"(34/81)":[214],"In":[230],"models,":[234],"there":[235],"were":[236],"(\u03b2":[241,251,262],"-0.71,":[243],"SE":[244,254,265],"1.12,":[246],"p":[247,257,268],"0.527),":[249],"0.24,":[253],"0.20,":[256],"0.226),":[259],"-0.16,":[264],"0.19,":[267],"0.386)":[270],"over":[272],"all":[273],"time":[274],"points.":[275],"Conclusions:":[276],"experience":[286],"similar":[287],"high":[290],"rates":[291],"distress.":[294],"These":[295],"findings":[296],"underscore":[297],"need":[299],"develop":[301],"supportive":[302],"interventions":[304],"for":[305],"AML,":[309],"regardless":[310],"their":[312],"initial":[313],"strategy.":[315]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2018-09-27T00:00:00"}